Blood pressure‐lowering drugs (BPLDs) vs placebo or no treatment: Deaths due to vascular events
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Blood pressure‐lowering drugs (BPLDs) vs placebo or no treatment Vascular death · patients with a history of TIA or stroke Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty). Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in… (2018) · Cochrane Headline outcomes only | RR 0.85 [0.76, 0.95] | 6 studies · 34747 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of… 2018 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.